Tumor necrosis factor (TNF) induction from monocyte/macrophages by Candida species

Immunobiology

Volumn 196, Issue 4, 1996, Pages 363-374

  Aybay, Cemalettin ^a   Imir, Turgut ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIGEN; MANNAN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BIOASSAY; CANDIDA; CELL SIZE; CELL STRAIN L 929; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; YEAST CELL;

EID: 0030511754     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80059-3     Document Type: Article

References (46)

1. CASWELL, A. E., L. J. OLD, R. L. KASSEL, S. GREEN, N. FIORE, and B. WILLIAMSON. 1975. An endotocxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA. 72: 3666-3670.
2. BEUTLER, B., and A. CERAMI. 1986. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320: 584-588.
3. GLAUSER M. P., G. ZANETTI, J. D. BAUMGARTNER, and J. COHEN. 1991. Septic shock: pathogenesis Lancet 338: 732-736.
4. RUDDLE, N. H. 1987. Tumor necrosis factor and related cytotoxins, Immunol. Today 8: 129-130.
5. HAVELL. E. A. 1987. Production of tumor necrosis factor during murine listeriosis, J. Immunol. 139: 4225-4231.
6. SLAGLE, D. C., R. A. COX, and U. KURUGANTI. 1989. Induction of tumor necrosis factor-α by spherules of Coccidiodes immitis, Infect. Immun. 57: 1916-1921.
7. KERN P., C. J. HEMMER, J. v. DAMME, H. J. GRUSS, M. DIETRICH. 1989. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87: 139-143.
8. WILLAMS D. M., L. F. BONEWALD, G. D. ROODMAN, G. I. BYRNE, D. M. MAGEE, and J. SCHACHTER. 1989. Tumor necrosis factor-α is a cytokine by murine Chlamydia trachomatis infection. Infect. Immun. 57: 1351-1355.
9. VYAKARNAM, A., P. MATEAR, A. MEAGER, G. KELLY, B. STANLEY, I. WELLER, and P. BEVERLEY. 1991. Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin. Exp. Immunol. 84: 109-115.
10. FAST, D. J., P. M. SCHLIEVERT, and R. D. NELSON. 1988. Nonpurulent response to toxic shock syndrome toxin-1 producing Staphylococcus aureus; relationship to toxin-stimulated production of tumor necrosis factor. J. Immunol. 140: 949-953.
11. PENNICA, D., G. E. NEDWIN, J. S. HAYFLICK, P. H. SEEBURG, R. DERYNCK, M. A. PALLADINO, W. J. KOHR, B. B AGGARWAL, and D. V. GOEDDEL. 1984. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312: 724-729.
12. WILLIAMSON, B. D., E. A. CARSWELL, B. Y., RUBIN, J. S. PRENDERGAST, and L. J. OLD. 1983. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human Interferon. Prod. Natl. Acad. Sci. USA. 80: 5397-5401.
13. WAAGE, A., and S. STEINSHAMN. 1993. Cytokine mediators of septic infections in the normal and granulocytopenic host. Eur. J. Haematol. 50: 243-249.
14. SHERON, N., and R. WILLIAMS. 1992. IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha, Clin. Exp. Immunol. 89: 100-103
15. BEUTLER, B., and A. CERAMI. 1989. The biology of cachectin/TNF-α primary mediator of the host response, Ann. Rev. Immunol. 7: 625-655.
16. SMITH, J. G., M. D. MAGEE, D. M. WILLIAMS, and J. R. GRAYBILL. 1990. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J. Infect. Dis. 162: 1349-1353.
17. TAVERNE, J., J. TAVERNIER, W. FIERS, and J. H. L. PLAYFAIR. 1987. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro, Clin. Exp. Immunol. 67: 1-4.
18. ALLENDOERFER, R., D. M. MAGEE, J. G. SMITH, L. BONEWALD, and J. R. GRAYBILL. 1993. Induction of tumor necrosis factor-α in murine Candida albicans infection. J. Infect. Dis. 167: 1168-1172.
19. TRACEY, K. J., B. BEUTLER, S. F. LOWRY, J. MERRYWEATHER, S. WOLPE, I. W. MILSARK, R. J. HARIRI, T. J. FAHEY III, A. ZENTELLA, J. D. ALBERT, T. G. SHIRES, and A. CERAMI. 1986. Shock and tissue injury induced by recombinant human cachectin, Nature 234: 470-474.
20. KARKAR, A. M., Y. KOSHINO, S. J. CASHMAN, A. C. DASH, J. BONNEFOY, A. MEAGER, and A. J. REES. 1992. Passive immunization against tumour necrosis factor-alpha (TNF-α) and IL-1β protects from LPS enhancing glomerular injury in nephortoxic in rats, Clin. Exp. Immunol. 90: 312-318.
21. TRACEY, K. J., Y. FONG, D. G. HESSE, K. R: MANOGUE, A. T. LEE, G. C. KUO, S. F. LOWRY, and A. CERAMI. 1987. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia, Science 330: 662-664.
22. BEUTLER, B., I. W. MILSARK, and A. C. CERAMI. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin, Science 229: 869-871.
23. SILVA, A. T., K. F. BAYSTON, and J. COHEN. 1990. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock, J. Infect. Dis. 162: 421-427.
24. BURCHARD, K. W., L. B. MINOR, G. J. SLOTMAN, and D. S. GANN. 1983. Fungal sepsis in surgical patients, Arch. Surg. 118: 217-221.
25. HORN, R., B. WONG, T. E. KIEHN, and D. ARMSTRONG.1985. Fungemia in a cancer hospital: changing frequency earlier onset, and result of therapy, Rev. Infect. Dis. 7: 646-655.
26. DYESS, D. L., N. R. GARRISON, and D. E. FRY. 1985. Candida sepsis, Arch. Surg. 120: 345-348.
27. JR. EDWARDS, J. E. 1991. Invasive Candida infections, N. Engl. J. Med. 324: 1060-1062
28. KENNEDY, M. J., and P. A. VOLZ. 1985. Ecology of Candida albicans gut colonization inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antogonism, Infect. Immun. 49: 654-663.
29. DJEU, J. Y., D. K. BLANCHARD, A. L. RICHARDS, and H. FRIEDMAN. 1988. Tumor necrosis factor inductiion by Candida albicans from human natural killer cells and monocytes, J. Immunol. 141: 4047-4052.
30. VECCHIARELLI, A., M. PUEITI, A. TOROSANTUCCI, A. CASSONE, and F. BISTONI. 1991. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall, Cell. Immunol. 134: 65-76.
31. JOUAULT, T., A. BERNIGAUD, G. LEPAGE, P.A. TRINEL, and D. POULAIN. 1994. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-α from human and murine macrophages, Immunol. 83: 268-273.
32. RIIPI, L., and E. CARLSON.1990.. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase, Infect. Immun. 58: 2750-2754.
33. CUTLER, J. E. 1991. Putative virulence factors of Candida albicans, annu. Rev. Microbiol. 45: 187-218.
34. AYBAY, C., T. IMIR, and H. OKUR. 1995. The effect of omeprazole an human natural killer cell activity, Gen. Pharmac. 26: 1413-1418.
35. SIMPSON, S. Q., R. SINGH, and D. E. BICE. 1994.Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-α production by murine macrophages. Am. J. Respir. Cell Mol. Biol. 10: 284-289.
36. TAYLOR, M. E., and K. DRICKAMER. 1993. Structural requirments for high affinity binding of complex ligands by the macrophage mannose receptor. J. Biol. Chem. 268: 399-404
37. GIAMIS, J., Y. LOMBARD, P. FONTENEAU, C. D. MULLER, R. LEVY, M. MAKAYA-KUMBA, J. LAZDINS, and P. POINDRON. 1993. Both mannose and beta-glucan receptors are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by murine macrophages. J. Leukoc. Biol. 54: 564-571.
38. SCHLEUSINGER, L. S., S. R. HULL, and T. M. KAUFMAN. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages, J. Immunol. 152: 4070-4049.
39. PODZORSKI, R. P., G. R. GRAY, and R. D. NELSON. 1990. Different effects of native Candida albicans mannan and mannan derived oligosaccharides on antigen-stimulated lymphoprohferation in vitro, J. Immunol. 44: 707-716.
40. KOCOUREK, J., and C. E. BALLOU. 1969. Method for fingerprinting yeast cell wall mannans, J. Bacteriol. 100: 1175-1181.
41. HOSTETTER, M. K. 1994. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces, Clin. Microbiol. Rev. 7: 29-42.
42. DOMER, J. E., P. W. STASHAK, K. ELKINS, B. PRESCOTT, G. CALDES, and P. J. BAKER. 1986. Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive componente, Cell. Immunol. 101: 403-414.
43. GARNER, R. E., K. RUBANOWICE, R. T. SAWYER, and J. A. HUDSON. 1994. Secretion of Tnf-alpha by alveolar macrophages in response to Candida albicnas mannan, J. Leukoc. Biol. 55: 161-168.
44. MEUNIER-CARPENTIER, F.,T. E. KIEHN, and D. ARMSTRONG. 1981. Fungimia in the immunocompromised host: changing patterns, antigenemia, high mortality, Am J. Med. 71: 363-370.
45. KOBAYASHI, K., and H. SUGINAKA. 1984. Comparison of cell wall and membrane proteins form eight Candida species, Sabouraudia, 22: 341-344.
46. NAKAMURA, A. N. ISHIKAWA, and H. SUZUKI. 1991. Diagnosis of invasive candidasis by detection of mannan antigen by using the avidin-biotin enzyme immunoassay, J. Clin. Microbiol. 29: 2363-2367.